Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Johnna Varghese, Ph.D.

Concepts (58)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Johnna Varghese's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Johnna Varghese has written about over time.
Inflammation Mediators, 1 publications between 2018 and 2018, average publication date March 2018. Oxidative Stress, 1 publications between 2018 and 2018, average publication date March 2018. Foam Cells, 2 publications between 2018 and 2021, average publication date April 2020. Inflammasomes, 2 publications between 2018 and 2021, average publication date April 2020. Atherosclerosis, 3 publications between 2018 and 2024, average publication date July 2020. Flavonols, 2 publications between 2019 and 2021, average publication date August 2020. Lipoproteins, LDL, 4 publications between 2018 and 2024, average publication date January 2021. Sterol Regulatory Element Binding Protein 1, 3 publications between 2018 and 2023, average publication date April 2021. Hydroxymethylglutaryl CoA Reductases, 1 publications between 2021 and 2021, average publication date October 2021. Hypolipidemic Agents, 1 publications between 2021 and 2021, average publication date October 2021. U937 Cells, 1 publications between 2021 and 2021, average publication date October 2021. Silymarin, 1 publications between 2024 and 2024, average publication date January 2024. Receptors, Immunologic, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Varghese's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (58)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.